🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies the side effects and best dose of alisertib when...
Status
Completed
Location
Mayo Clinic
Start Date
2014-12-05
Trial ID
NCT02219789
Treatments Being Tested
To allow a patient continued access to MLN8237...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT03005262
Treatments Being Tested
This phase I/Ib trial studies the side effects and best dose of alisertib w...
Status
Completed
Location
University of California, San Francisco
Start Date
2019-11-12
Trial ID
NCT04085315
Treatments Being Tested
This is an open-label, multicenter, phase 1 study of MLN8237 in participant...
Status
Completed
Location
Multiple Locations
Start Date
2008-07-11
Trial ID
NCT00697346
Treatments Being Tested
The purpose of this study is to assess the mass balance (i.e. cumulative ex...
Status
Completed
Location
Comprehensive Clinical Development
Start Date
2013-01-24
Trial ID
NCT01714947
Treatments Being Tested
This phase II trial studies how well alisertib works in treating patients w...
Status
Completed
Location
Providence Hospital
Start Date
2011-10
Trial ID
NCT01466881
Treatments Being Tested
The primary purpose of this study is to determine the safety profile and th...
Status
Completed
Location
Massachusetts General Hospital Cancer Center
Start Date
2015-01-14
Trial ID
NCT02327169
Treatments Being Tested
This is a multicenter, dose escalation, phase 1 study of MLN8237 in adult p...
Status
Completed
Location
Ciutat Sanitaria Vall d'Hebron - Servicio de Oncologia
Start Date
2007-10-22
Trial ID
NCT00651664
Treatments Being Tested
The goal of this clinical research study is to find the highest tolerable d...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-09
Trial ID
NCT02812056
The purpose of this study is to evaluate the effect of moderate or severe h...
Status
Completed
Location
Multiple Locations
Start Date
2014-08-21
Trial ID
NCT02214147
Treatments Being Tested